Romy De Laat-Kremers, PhD

Post-doctoral Research Project Leader
Department of Data Analysis and Artificial Intelligence, Synapse Research Institute, Maastricht, the Netherlands

Dr. Romy de Laat-Kremers is the Research Project Leader at the Department of Data Analysis and Artificial at Intelligence Synapse Research Institute (Maastricht, the Netherlands). She obtained her Research Masters Degree in Cardiovascular Biology and Medicine in 2011 at Maastricht University. From 2011 until 2016, Dr. de Laat-Kremers was enrolled in a PhD program at Synapse Research Institute, studying the computational modeling of coagulation and thrombin generation. This research resulted in the development of a computational model that allows to study the thrombin generation process in more detail, by quantifying parameters of prothrombin conversion and thrombin inactivation. This method was named “Thrombin Dynamics Analysis”, and has been applied in many clinical studies since its development. In 2016, Dr. de Laat-Kremers successfully defended her PhD thesis entitled “Thrombin Dynamics”, after which she continued working at Synapse Research Institute. Dr. de Laat-Kremers is currently working at Synapse Research Institute as a Research Project Leader at the interface of coagulation research, computational modeling and artificial intelligence. Her main scientific interests are thrombin generation, thrombin dynamics, and the application of artificial intelligence methods to facilitate the translation of newly acquired scientific data in the field of coagulation research to the clinic.

Presentation(s):

• PB0086 - Haemostatic differences between SARS-CoV-2 PCR-positive and -negative patients at the time of hospital admission

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0174 - Activated Factor XI as Activator of Thrombin Generation to Increase Assay Sensitivity

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• OC 44.5 - High α2-macroglobulin levels are a risk factor for cardiovascular events

  Monday, July 11, 2022
  3:45 PM – 4:00 PM

• PB0539 - Low antithrombin levels are associated with low risk of cardiovascular death but are a risk factor for cancer mortality

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0591 - Coagulation parameters predict COVID-19-related thrombosis in a neural network with a positive predictive value of 98%

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0742 - Functional changes in platelets and coagulation during asexual and sexual parasitemia in a controlled human malaria infection

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB1041 - Hypoxia increases coagulation which is more pronounced in women but is counterbalanced by a decreased platelet reactivity

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM